Jennifer R Emberger, LEP Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 440 Stevens Ave Ste 200, Solana Beach, CA 92075 Phone: 858-401-9439 |
News Archive
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has reached agreement with the U.S. Food and Drug Administration for two special protocol assessments for the Company's pivotal Phase 3 program with NAV5001 as an aid in the differential diagnosis of Parkinsonian Syndromes from non-Parkinsonian tremor.
Immune globulin replacement began decades ago as a treatment for patients who could not make their own protective antibodies, but has proven to have much broader benefits than originally expected.
In conjunction with Better Speech and Hearing Month, Sonus, a national strategic partner of the American Diabetes Association, has launched a PSA initiative to inform individuals of the link between hearing loss and diabetes. The connection stems from solid research including a study published in the Annals of Internal Medicine, stating hearing loss is about twice as common in adults with diabetes compared to those who do not have the disease.
The PricewaterhouseCoopers study that the Community Oncology Alliance (COA) commissioned shows that an estimated $13 billion will be saved from Medicare spending for cancer care through 2013. This is $8.8 billion more than the original intent of Congress in passing the Medicare Modernization Act (MMA).
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced that earlier today it filed a notice of intention to make a proposal to its creditors under the Bankruptcy and Insolvency Act with KPMG Inc. in order to provide the company with the liquidity it requires to pursue its solicitation process.
› Verified 2 days ago